A Study to Evaluate the Efficacy of Defibrotide in Patients With Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome following Hematopoietic Stem Cell Transplantation (HSCT)

Trial Profile

A Study to Evaluate the Efficacy of Defibrotide in Patients With Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome following Hematopoietic Stem Cell Transplantation (HSCT)

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 25 Jun 2017

At a glance

  • Drugs Defibrotide (Primary)
  • Indications Hepatic veno-occlusive disease
  • Focus Adverse reactions; Expanded access; Therapeutic Use
  • Most Recent Events

    • 25 Jun 2017 Results of subgroup analysis (n=1000) presented at the 22nd Congress of the European Haematology Association
    • 25 Jun 2017 Results of a post hoc analysis presented at the 22nd Congress of the European Haematology Association
    • 06 Dec 2016 Results of exploratory age group analysis (n=755) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top